Parkinson’s disease - search results

Here, OilsBySimpson explains the findings of a new study on 400 patients prescribed cannabidiol (CBD). The results show promise for pain, anxiety, and depression.

Jay Sibbitts, Prof Dr Stefan H. Bossmann and Prof Dr Christopher T. Culbertson, from Kansas State University, Department of Chemistry in the U.S., underline microfluidic detection of intracellular nitric oxide levels.

Shinichi Tokuno from Voice Analysis and Measurement of Pathophysiology, Department of Bioengineering, at the University of Tokyo, shares with us what we need to know about the detection of cognitive impairment with the benefit of voice analysis technology concerning the ageing of people globally.

In this article, Dr Gerry Morrow shares his thoughts on the medical use of cannabinoids and marijuana.

In this article, Dr Hans-Günter Weeß explains the connection between sleep, mental health and strengthening resilience.

Here, content director Joseph at TheAmsterdam.com, discusses the effects of cannabidiol on the brain.

Ruth Smith, COO at Christchurch Group, applauds England's 27 Major Trauma Centres provision of rehabilitation prescriptions for Acquired Brain Injury care.

George Ordiway, a PhD student in the laboratory of Dr. Jason Tait Sanchez at Northwestern University, discusses how patterned activity in the nervous system permits a wide range of biologically relevant functions, including auditory development.

Shinichi Tokuno from the Department of Voice Analysis of Pathophysiology, Graduate School of Medicine, at the University of Tokyo, lifts the lid on voice analysis technology for healthcare.

Alex Schiphorst, Science Communication and Policy Officer discusses the vital role of chemistry when it comes to the future of Europe.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group shares a perspective on the present status and potential evolution when it comes to cannabinoids for therapeutic purposes.

Here we provide a brief introduction to the medical benefits of CBD and medical Cannabis, with an overview of treatments that have been implemented.

European Cannabis Holdings (ECH) has announced plans to open The Medical Cannabis Clinics in a step toward aiding patients living with a range of chronic conditions.

We look at the the National Institute on Deafness and Other Communication Disorders (NIDCD)'s work around helping those with hearing loss.

Andrea Varrone studies the importance of molecular imaging to provide personalised medicine and improve care for patients with neurodegenerative disorders

To mark its 50-year anniversary, the National Eye Institute (NEI) takes stock of its progress in advancing vision research and developing new therapies to treat blinding diseases

Dr Gerry Morrow shares his thoughts on the current state of play when it comes to the early diagnosis of neurodegenerative disorders, and asks the questions, can we screen, and should we screen?

The vital work of the National Institute on Deafness and Other Communication Disorders (NIDCD) and The National Institute of Neurological Disorders and Stroke (NINDS) are explored here by Open Access Government, with a special focus on neurodegenerative disorders.

Stephen T Holgate, Special Advisor to the Royal College of Physicians (RCP) on Air Quality and MRC Clinical Professor of Immunopharmacology, University of Southampton takes the stance that indoor air pollution is a neglected yet important risk to public health.

Frédéric Destrebecq, Vinciane Quoidbach and Marijn Scholte from The European Brain Council (EBC) detail how the future of healthcare and improved brain health can be achieved through implementing digital health technology The European Brain Council (EBC) is a Brussels-based organisation that gathers patient associations, major brain-related societies, as well as...